Ir Biosciences Holdings Inc (IRBS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2006 | 12-2005 | 12-2004 | 12-2003 | 12-2002 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,480 | -4,590 | -5,300 | -1,850 | -200 |
| Depreciation Amortization | 8 | 3 | 710 | 320 | 0 |
| Other Working Capital | -30 | 110 | 170 | 360 | 50 |
| Other Operating Activity | -528 | 3,167 | 3,380 | 180 | -20 |
| Operating Cash Flow | $-2,030 | $-1,310 | $-1,040 | $-990 | $-170 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -30 | 0 | -5 | -3 | 0 |
| Investing Cash Flow | $-30 | $0 | $-5 | $-3 | $0 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 4,550 | 1,180 | 2,000 | 970 | 170 |
| Financing Cash Flow | $4,550 | $1,180 | $2,000 | $970 | $170 |
| Beginning Cash Position | 260 | 970 | 10 | 30 | 5 |
| End Cash Position | 2,750 | 260 | 970 | 10 | 0 |
| Net Cash Flow | $2,480 | $-700 | $960 | $-20 | $-5 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,030 | -1,310 | -1,040 | -990 | -170 |
| Free Cash Flow | -2,030 | -1,310 | -1,040 | -990 | -170 |